BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 24090732)

  • 21. Evaluation of Acid Tolerance of Drugs Using Rats and Dogs Controlled for Gastric Acid Secretion.
    Kosugi Y; Yamamoto S; Sano N; Furuta A; Igari T; Fujioka Y; Amano N
    J Pharm Sci; 2015 Sep; 104(9):2887-93. PubMed ID: 25720462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human.
    Wu Y; Loper A; Landis E; Hettrick L; Novak L; Lynn K; Chen C; Thompson K; Higgins R; Batra U; Shelukar S; Kwei G; Storey D
    Int J Pharm; 2004 Nov; 285(1-2):135-46. PubMed ID: 15488686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a preclinical food effect model.
    Lentz KA; Quitko M; Morgan DG; Grace JE; Gleason C; Marathe PH
    J Pharm Sci; 2007 Feb; 96(2):459-72. PubMed ID: 17075867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification of gastric pH in the fasted dog.
    Polentarutti B; Albery T; Dressman J; Abrahamsson B
    J Pharm Pharmacol; 2010 Apr; 62(4):462-9. PubMed ID: 20604835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of the dog in toxicity tests on pharmaceutical compounds.
    Parkinson C; Grasso P
    Hum Exp Toxicol; 1993 Mar; 12(2):99-109. PubMed ID: 8096722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors influencing the gastric residence of dosage forms in dogs.
    Martinez MN; Papich MG
    J Pharm Sci; 2009 Mar; 98(3):844-60. PubMed ID: 18661535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Issues related to the use of canines in toxicologic pathology--issues with pharmacokinetics and metabolism.
    Tibbitts J
    Toxicol Pathol; 2003; 31 Suppl():17-24. PubMed ID: 12597427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetic and metabolic differences between dog breeds: their impact on canine medicine and the use of the dog as a preclinical animal model.
    Fleischer S; Sharkey M; Mealey K; Ostrander EA; Martinez M
    AAPS J; 2008; 10(1):110-9. PubMed ID: 18446511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of the pentagastrin dog model to explore the food effects on formulations in early drug development.
    Zane P; Guo Z; MacGerorge D; Vicat P; Ollier C
    Eur J Pharm Sci; 2014 Jun; 57():207-13. PubMed ID: 24090732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interests of the 'artificial stomach' techniques to study antacid formulations: comparison with in vivo evaluation.
    Vatier J; Célice-Pingaud C; Farinotti R
    Fundam Clin Pharmacol; 1998; 12(6):573-83. PubMed ID: 9818289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo methods for drug absorption - comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects.
    Sjögren E; Abrahamsson B; Augustijns P; Becker D; Bolger MB; Brewster M; Brouwers J; Flanagan T; Harwood M; Heinen C; Holm R; Juretschke HP; Kubbinga M; Lindahl A; Lukacova V; Münster U; Neuhoff S; Nguyen MA; Peer Av; Reppas C; Hodjegan AR; Tannergren C; Weitschies W; Wilson C; Zane P; Lennernäs H; Langguth P
    Eur J Pharm Sci; 2014 Jun; 57():99-151. PubMed ID: 24637348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current methods for predicting human food effect.
    Lentz KA
    AAPS J; 2008 Jun; 10(2):282-8. PubMed ID: 18500565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Key Considerations in Designing Oral Drug Delivery Systems for Dogs.
    Song Y; Peressin K; Wong PY; Page SW; Garg S
    J Pharm Sci; 2016 May; 105(5):1576-1585. PubMed ID: 27056627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Food for thought: formulating away the food effect - a PEARRL review.
    O'Shea JP; Holm R; O'Driscoll CM; Griffin BT
    J Pharm Pharmacol; 2019 Apr; 71(4):510-535. PubMed ID: 29956330
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.